Shilpa Medicare Ltd share price logo

Shilpa Medicare Ltd

NSE: SHILPAMED

BSE: 530549

Small Cap

Healthcare Sector

415.90

-4.20

(-1.00%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Shilpa Medicare Stock Performance

as on April 13, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹404.55
    ₹423.00
    downward going graph

    2.73%

    Downside

    1.71%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    ₹259.50
    ₹500.00
    downward going graph

    37.61%

    Downside

    20.22%

    Upside

    downward going graph

Shilpa Medicare share price movements today

Previous Close
₹420.10
Open
₹410.05
Volume
2.37L
Upper Circuit
₹504.10
Lower Circuit
₹336.10
Day's Low - High
₹404.55 - ₹423.00
52 Week Low - High
₹259.50 - ₹500.00

Shilpa Medicare Historical Returns

1 Month Return
+ 31.61 %
3 Month Return
+ 41.39 %
1 Year Return
+ 26.86 %
3 Year Return
+ 230.34 %
5 Year Return
+ 121.07 %

Shilpa Medicare Fundamentals

as on April 13, 2026 at 4:01 pm IST

Market Cap

₹8,134.25 Cr

Return on Equity (ROE)

3.92

PE Ratio (TTM)

50.44

Return on capital employed (ROCE)

6.2

Industry PE ratio

41.39

Beta (LTM)

0.98

P/B Ratio

2.4

Dividend Yield

0.15

PEG Ratio

14.15

Quarterly Earnings Growth YOY

40.28

EPS (TTM)

4.005

Sector

Pharmaceuticals

Book Value

121.29

Technical Analysis

Shilpa Medicare Stock Valuation

as on April 13, 2026 at 4:01 pm IST

Shilpa Medicare in the last 5 years

  • Overview

  • Trends

Lowest (-6576.49x)

March 28, 2024

Industry (41.39x)

April 13, 2026

Today (50.44x)

April 13, 2026

Highest (503.72x)

February 21, 2023

LowHigh

Today’s Price to Earnings Ratio: 50.44x

Shilpa Medicare Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Shilpa Medicare with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
BUY8,134.2524.21%0.60781,286
BUY13,718.86-5.26%0.682641,197
BUY14,214.344.53%0.718367,234
BUY4,620.86-2.44%1.88-34371
BUY12,956.9236.68%0.672441,515

Market expectation of Shilpa Medicare Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Shilpa Medicare Stock’s Investor Sentiment and Interest

Search interest for Shilpa Medicare Ltd Stock has increased by 2% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:2% versus previous 30 day period

Shilpa Medicare Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Sales
260.17
312.98
286.76
291.69
292.51
343.8
319.3
330.8
321.46
369.97
409.73
Other Income
1.93
1.81
1.94
8.62
9.52
4.99
1.52
9.9
6.38
1.75
0.81
Total Income
262.11
314.79
288.7
300.32
302.04
348.79
320.82
340.71
327.84
371.72
410.54
Expenses
213.92
254.59
221.6
221.77
222.51
258.18
238.66
282.15
230.55
261.8
308.64
Operating Profit
46.25
58.39
65.16
69.92
70
85.62
80.64
48.65
90.91
108.17
101.09
Operating Profit Margin %
17.78%
18.66%
22.72%
23.97%
23.93%
24.9%
25.26%
14.71%
28.28%
29.24%
24.67%
Profit Before Interest, Tax and Depreciation
48.19
60.2
67.09
78.54
79.52
90.61
82.17
58.56
97.28
109.92
101.9
Interest
18.15
23.24
26.22
24.2
23.74
25.55
11.75
14.49
18.78
15.67
10.68
Depreciation
26.75
27.79
26.71
26.63
27.11
28.28
28.81
28.79
28.92
29.82
30.36
Profit Before Tax
3.29
9.17
14.16
27.71
28.67
36.78
41.61
15.28
49.58
64.43
60.86
Tax Paid
2.12
7.6
9.46
3.21
14.62
18.83
9.82
0.77
2.7
20.37
16.28
Profit After Tax
1.18
1.57
4.7
24.5
14.06
17.94
31.78
14.51
46.89
44.07
44.58
Total Net profit including share of profit / Loss from associate company
1.18
1.57
4.7
24.5
14.06
17.94
31.78
14.51
46.89
44.07
44.58
EPS
0.14
0.19
0.53
2.82
1.46
1.83
3.25
1.48
4.79
5.5
2.36
Actual EPS
0.14
0.19
0.53
2.82
1.46
1.83
3.25
1.48
4.79
5.5
2.36
Adjusted EPS
0.07
0.1
0.27
1.41
0.73
0.92
1.63
0.74
2.4
2.75
2.36
Diluted EPS
0.14
0.19
0.53
2.82
1.46
1.83
3.25
1.48
4.79
5.5
2.36

Shilpa Medicare Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
788.83
733.39
907.91
901.13
1,145.52
1,050.11
1,151.6
1,286.41
Other Income
21.68
33.6
16.94
90.98
23.04
17.4
14.3
23.3
Total Income
810.5
766.98
924.85
992.11
1,168.56
1,067.51
1,165.9
1,309.71
Expenses
633.85
585.57
688.46
721.21
945.33
951.64
911.89
998.85
Operating Profit
154.98
147.82
219.45
179.92
200.19
98.47
239.71
287.56
Operating Profit Margin %
19.65%
20.16%
24.17%
19.97%
17.48%
9.38%
20.82%
22.35%
Profit Before Interest, Tax and Depreciation
176.65
181.42
236.39
270.9
223.23
115.87
254.01
310.86
Interest
2.66
3.68
4.56
21.87
41.17
58.65
91.81
75.53
Depreciation
37.22
42.06
43.78
53.98
79.8
95.5
107.87
112.99
Profit Before Tax
136.77
135.68
188.05
195.05
102.26
-38.28
54.33
122.34
Tax Paid
33.91
26.18
33.49
48.85
41.68
-7.31
22.38
44.04
Profit After Tax
102.86
109.5
154.56
146.2
60.58
-30.97
31.96
78.3
Total Net profit including share of profit / Loss from associate company
102.86
109.5
154.56
146.2
60.58
-30.97
31.96
78.3
EPS
12.91
13.77
19.15
18.13
7.26
-3.74
3.67
8.04
Actual EPS
12.91
13.77
19.15
18.13
7.26
-3.74
3.67
8.04
Adjusted EPS
6.46
6.89
9.57
9.07
3.63
-1.87
1.84
4.02
Diluted EPS
12.91
13.77
19.15
18.13
7.26
-3.74
3.67
8.04

Shilpa Medicare Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
128.7
37.48
44.92
146.78
124.38
46.93
105.13
179.92
136.67
132.18
Cash Flow from Investing Activities
-104.07
-257.78
-10.16
22.96
-289.69
-404.28
-285.51
-232.27
-170.77
-198.06
Cash Flow from Financing Activities
-19.65
312.71
-60.91
10.06
175.51
436.37
82.86
45.8
46.77
62.65
Net Cash Flow
2.82
92.92
-26.15
-39.47
10.18
79.03
-97.51
-6.55
12.68
-3.23

Shilpa Medicare Stock Shareholding Pattern

Numbers in percentages

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Apr 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Promoters
50.01%
50.01%
50.01%
50.01%
44.39%
44.39%
44.33%
44.23%
44.23%
44.23%
44.23%
40.13%
40.13%
DII
0%
0.41%
0.06%
1.59%
6.13%
7.61%
8.18%
8.27%
7.55%
7.46%
7.67%
8.33%
8.58%
FII
0%
8.6%
8.52%
0%
0%
9.08%
9.58%
9.9%
10.97%
11.2%
10.92%
10.97%
11.08%
Public
39.37%
40.99%
41.41%
42.62%
38.39%
38.92%
37.9%
37.6%
37.25%
37.11%
37.18%
40.56%
40.21%
Total Outstanding Shares
8,68,01,898
8,68,01,898
8,68,01,898
8,68,01,898
9,77,90,908
9,77,90,908
9,77,90,908
9,77,90,908
9,77,90,908
9,77,90,908
9,77,90,908
19,55,81,816
19,55,81,816
Total Shareholders
50,434
44,094
43,630
44,793
44,809
41,072
42,784
49,034
50,108
48,636
52,065
53,799
53,410

Mutual Funds that own Shilpa Medicare Stock

Check out the Mutual Funds with significant holdings in Shilpa Medicare.

Shilpa Medicare Corporate Actions

View detailed summary of the earnings and dividend history of Shilpa Medicare.

  • Shilpa Medicare Ltd Earnings Results

    Shilpa Medicare Ltd’s net profit jumped 40.28% since last year same period to ₹44.58Cr in the Q3 2025-2026. On a quarterly growth basis, Shilpa Medicare Ltd has generated 1.16% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Shilpa Medicare Ltd Dividends May,2025

    In the quarter ending March 2025, Shilpa Medicare Ltd has declared dividend of ₹1.00 per share on 26 May 2025 - translating a dividend yield of 0.24%.

    Read More about Dividends

Indices Featuring Shilpa Medicare Stock

Check stock indices that include Shilpa Medicare.

BSE Healthcare

₹42,507.93

-0.26 (111.47%)

Insights on Shilpa Medicare Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 10.97% to 11.08% in Mar 2026 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 327.84 Cr → 410.54 Cr (in ₹), with an average increase of 10.6% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 44.07 Cr → 44.58 Cr (in ₹), with an average increase of 1.1% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, SHILPAMED stock has moved up by 31.6%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 40.13% of holdings in Mar 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 29.8% return, outperforming this stock by 2.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Lupin Ltd has given 251.8% return, outperforming this stock by 21.4%

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 5.20% to 5.15% in Mar 2026 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 40.56% to 40.21% in Mar 2026 quarter

About Shilpa Medicare Ltd

Shilpa Medicare Limited (SML) was established in 1987 and converted to a public limited company in 1993. They are one of the leading API and formulations manufacturers, with expertise in oncology and non-oncology medicines, with over 44 APIs and 16 injectable dosage forms and 19 oral solid dosage forms. SML deploy sophisticated technology in order to comply with international standards. In 2015, funds were raised by allotting 1.76 Mn equity shares at Rs. 423/ share, and in 2016, the face value of equity shares was split into two equity shares of Rs.1/ each. Raichem Medicare Pvt. Ltd., a subsidiary of SML successfully installed all machinery and recruited personnel. During FY16, they launched generic versions of Vidaza Injection and Xeloda Tablets. In 2017, Navya Biologicals Private Limited was acquired and in 2019, they invested Rs 22.71 cr in Shilpa Therapeutics Pvt. Ltd and disinvested 24% stake in Raichem Medicare Pvt. Ltd. In 2021, they launched a pediatric dose paracetamol oral thin film, Molshil and acquired stake in FTF Pharma Pvt. Ltd, Koanaa Healthcare Canada, etc. In 2022, they approved Slump sale of Active Pharmaceutical Ingredient API Business to Shilpa Pharma Lifesciences Limited.

Revenue: ₹409.73Cr as on December 2025 (Q3 FY26)
Net Profit: ₹44.58Cr as on December 2025 (Q3 FY26)
Listing date: 03 Dec, 2009
Chairperson Name: Omprakash Inani
OrganisationShilpa Medicare Ltd
IndustryPharmaceuticals
CEOOmprakash Inani
E-voting on sharesClick here to vote

FAQs

What is Shilpa Medicare share price today?

Shilpa Medicare share price today stands at ₹415.9 as on at the close of the market. Shilpa Medicare share today touched a day high of ₹423 and a low of ₹404.55.

What is the 52 week high and 52 week low range for Shilpa Medicare share?

Shilpa Medicare touched a 52 week high of ₹500 and a 52 week low of ₹259.5. Shilpa Medicare share price today i.e. is closed at ₹415.9, which is -16.82% down from its 52 week high and 60.27% up from its 52 week low.

What is Shilpa Medicare's market capitalisation today?

Shilpa Medicare market capitalisation is ₹8,134.25 Cr as on .

How to buy Shilpa Medicare shares?

To buy Shilpa Medicare shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for SHILPAMED or Shilpa Medicare Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Shilpa Medicare shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Shilpa Medicare trading volume today?

Shilpa Medicare trading volume is 2.37L as on . This means that 2.37L shares of Shilpa Medicare were bought and sold on the stock market during today's trading session.